MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, ...

Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain

During 12-week post-treatment period, nimacimab plus semaglutide blunts weight regain compared to semaglutide alone in subset ...
The Malaysian Reserve

Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations

Amid Soft Market Consumption Trends, Achieved Q3 2025 Dollar, Unit and Volume Share(1) Gains in 5 of 7 Over-The-Counter ("OTC ...
The Malaysian Reserve

Bio-Techne Releases First Quarter Fiscal 2026 Results

Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September ...
Tax Guru

Information Technology (IT) are Vital for Statutory Auditors in India

Indian statutory auditors must embrace IT proficiency and CAATs to manage ERP data and system controls. Non-IT friendly ...
Junior Mining Network

Cameco announces third quarter results: financial performance on track for strong finish to the year; nuclear fundamentals strengthened by transformational partnership to ...

All amounts in Canadian dollars unless specified otherwise SASKATOON, Saskatchewan / Nov 05, 2025 / Business Wire / Cameco (TSX: CCO; NYSE: CCJ) ...

Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2025, provided an update on progress toward achieving key corporate objectives, and outlined its commercial, ...